About Guerbet
Guerbet is a company based in Villepinte (France) founded in 1926.. The company has 2,900 employees as of December 31, 2024. Guerbet offers products and services including Dotarem, Elucirem, OptiStar Elite, and OptiVantage. Guerbet operates in a competitive market with competitors including On Target Laboratories, Osprey Medical, RenalGuard Solutions, Cision Vision and Solstice Pharmaceuticals, among others.
- Headquarter Villepinte, France
- Employees 2900 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Guerbet Sa
-
Annual Revenue
$873.81 M (USD)7.05as on Dec 31, 2024
-
Net Profit
$16.71 M (USD)-32.61as on Dec 31, 2024
-
EBITDA
$108.16 M (USD)11.22as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
2900
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Guerbet
Guerbet is a publicly listed company on the EURONEXT with ticker symbol GBT in France, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Guerbet
Guerbet offers a comprehensive portfolio of products and services, including Dotarem, Elucirem, OptiStar Elite, and OptiVantage. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Contrast agent used for enhancing MRI diagnostic imaging
Agent for magnetic resonance imaging procedures
Device for delivering contrast in MRI scans
Multi-use injector for CT contrast administration
Unlock access to complete
Unlock access to complete
Funding Insights of Guerbet
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Guerbet
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Guerbet
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Guerbet Comparisons
Competitors of Guerbet
Guerbet operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as On Target Laboratories, Osprey Medical, RenalGuard Solutions, Cision Vision and Solstice Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Molecular imaging agents for cancer surgery are developed.
|
|
| domain | founded_year | HQ Location |
Technology to reduce contrast dye exposure
|
|
| domain | founded_year | HQ Location |
Technologies for the cardiac and vascular markets
|
|
| domain | founded_year | HQ Location |
High contrast real-time imaging devices are developed for medical visualization.
|
|
| domain | founded_year | HQ Location |
Ultrasound contrast agents are developed for diagnosing multiple diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Guerbet
Frequently Asked Questions about Guerbet
When was Guerbet founded?
Guerbet was founded in 1926.
Where is Guerbet located?
Guerbet is headquartered in Villepinte, France. It is registered at Villepinte, Ile-de-france, France.
How many employees does Guerbet have?
As of Dec 31, 2024, the latest employee count at Guerbet is 2,900.
What is the annual revenue of Guerbet?
Annual revenue of Guerbet is $873.81M as on Dec 31, 2024.
What does Guerbet do?
Guerbet was founded in 1926 and is headquartered in Villepinte, France. Operations focus on the medical imaging sector, where contrast media and delivery systems are provided for CT scans, Cath Lab procedures, MRI examinations, interventional radiology, and theranostic applications. A range of medical devices is also supplied for angiography, scanners, and MRI setups, supporting diagnostic and therapeutic needs in healthcare settings.
Who are the top competitors of Guerbet?
Guerbet's top competitors include On Target Laboratories, Osprey Medical and RenalGuard Solutions.
What products or services does Guerbet offer?
Guerbet offers Dotarem, Elucirem, OptiStar Elite, and OptiVantage.
Is Guerbet publicly traded?
Yes, Guerbet is publicly traded on EURONEXT under the ticker symbol GBT.
What is Guerbet's ticker symbol?
The ticker symbol of Guerbet is GBT on EURONEXT.